It has been shown that inhibition of aPKC enhances the anti-BC activity of the tumor necrosis factor α (TNF-α) [83], tamoxifen [84] and 5-fluorouracil or adoptive immunotherapy [85]. The gene discussed is TNF; the disease is breast cancer.